MICA-129 Met/Met contributes to the susceptibility of colorectal cancer
Open Access
- 19 December 2025
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (51) , e46637
Abstract
The highly polymorphic human major histocompatibility complex class I chain-related gene A (MICA) regulates immune surveillance and destroys tumor cells by activating its receptor, the natural killer group 2D. This study aimed to examine a single nucleotide polymorphism of this gene at codon 129 (MICA-129) in association with colorectal cancer (CRC). Using PCR sequencing, the MICA-129 polymorphism was examined in 104 patients with CRC and 536 healthy controls. Specific MICA-129 single nucleotide polymorphism was analyzed for its association with CRC susceptibility, clinical phenotypes, and selected CRC-associated microsatellite instability, driver gene mutation, immune checkpoint programmed death ligand 1, and diagnostic biomarkers carbohydrate antigen 19-9 and carcinoembryonic antigen. The MICA-129 heterozygous A/G (Met/Val) genotype was associated with less aggressive clinical characteristics, such as a reduced prevalence of the ulcerated subtype ( P = .0489, OR = 0.59) and lymph node involvement ( P = .0217, OR = 0.46). Conversely, the MICA-129 homozygous allele A/A (Met/Met) variant was related to more advanced clinical characteristics, such as increased tumor invasion depth (T3/4; P = .0261, OR = 2.10), driver gene mutation ( P = .0363, OR = 2.65), and KRAS mutation ( P = .0392, OR = 2.23). Additionally, patients with carbohydrate antigen 19-9-positive CRC had a lower MICA-129 Met/Val variation, whereas those with carcinoembryonic antigen-positive CRC had a higher MICA-129 Met/Met variant ( P = .0330/OR = 0.22 and P = .0034/OR = 2.99, respectively).Keywords
This publication has 31 references indexed in Scilit:
- Single-cell sequencing analysis reveals CHURC1 as a non-canonical oncoprotein governing goblet cell-driven colorectal tumorigenesisCellular Signalling, 2025
- Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunityCancer Cell, 2024
- Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancerImmunity, 2021
- MICA polymorphisms associated with antithyroid drug‐induced agranulocytosis in the Chinese Han populationImmunity, Inflammation and Disease, 2020
- NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer VaccinesCell, 2018
- Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK CellsCell, 2018
- Molecular Biomarkers for the Evaluation of Colorectal CancerThe Journal of Molecular Diagnostics, 2017
- The MICA-129Met/Val dimorphism affects plasma membrane expression and shedding of the NKG2D ligand MICAImmunogenetics, 2015
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian populationHuman Immunology, 2009